Trial intelligence / Profile preview

Aerosol tobramycin single-dose pilot study in adult cystic fibrosis patients

2011-001821-26Phase 3Completed

Sponsor
Policlinico di Milano
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of tobramycin in cystic fibrosis (CF), sponsored by Policlinico di Milano. Primary endpoint: Microbiological efficacy. Started Mar 2012; status: completed.

02

Drugs

tobramycin
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on 2011-001821-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001821-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call